The in vivo antitumor effects of type I-interferon against hepatocellular carcinoma: the suppression of tumor cell growth and angiogenesis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The in vivo antitumor effects of type I-interferon against hepatocellular carcinoma: the suppression of tumor cell growth and angiogenesis
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-09-18
DOI
10.1038/s41598-017-12414-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of sorafenib combined with low-dose interferon therapy for advanced hepatocellular carcinoma: a pilot study
- (2015) Norio Itokawa et al. International Journal of Clinical Oncology
- Hepatitis C virus relapse was suppressed by long-term self-injection of low-dose interferon in patients with chronic hepatitis C after pegylated interferon plus ribavirin treatment
- (2013) Tomoyuki Takashima et al. HEPATOLOGY RESEARCH
- Antiproliferative effects of sorafenib and pegylated IFN-α2b on human liver cancer cells in vitro and in vivo
- (2013) HIRONORI KUSANO et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Combined anti-tumor effects of IFN-α and sorafenib on hepatocellular carcinoma in vitro and in vivo
- (2012) Lijing Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
- (2012) Hashem B. El-Serag GASTROENTEROLOGY
- Management of HCC
- (2012) Carlos Rodríguez de Lope et al. JOURNAL OF HEPATOLOGY
- Anti-interferon-α neutralizing antibody is associated with nonresponse to pegylated interferon-α plus ribavirin in chronic hepatitis C
- (2012) F. Matsuda et al. JOURNAL OF VIRAL HEPATITIS
- NIH Image to ImageJ: 25 years of image analysis
- (2012) Caroline A Schneider et al. NATURE METHODS
- Anticarcinogenic impact of interferon therapy on the progression of hepatocellular carcinoma in patients with chronic viral infection
- (2011) Soji Shimomura et al. HEPATOLOGY RESEARCH
- Maintenance Peginterferon Therapy and Other Factors Associated With Hepatocellular Carcinoma in Patients With Advanced Hepatitis C
- (2010) Anna S. Lok et al. GASTROENTEROLOGY
- Effects of interferon treatment on development and progression of hepatocellular carcinoma in patients with chronic virus infection: A meta-analysis of randomized controlled trials
- (2010) Chuan-Hai Zhang et al. INTERNATIONAL JOURNAL OF CANCER
- Differential interferon signaling in liver lobule and portal area cells under treatment for chronic hepatitis C
- (2010) Masao Honda et al. JOURNAL OF HEPATOLOGY
- Antitumor effects of a combination of interferon-alpha and sorafenib on human renal carcinoma cell lines
- (2009) Shiro Tochizawa et al. BIOMEDICAL RESEARCH-TOKYO
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
- (2008) Scott M. Wilhelm et al. MOLECULAR CANCER THERAPEUTICS
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Selected Combination Therapy with Sorafenib: A Review of Clinical Data and Perspectives in Advanced Solid Tumors
- (2008) L. Dal Lago et al. ONCOLOGIST
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started